NCT06272526

Internet-Based Self-Help Intervention for Social Anxiety Symptoms

Acceptability and Effectiveness Study of Internet Based Social Anxiety Intervention for University Students in Turkey : A Randomized Controlled Trial
Anadolu University·ClinicalTrials.gov·otherNot yet recruiting
View on ClinicalTrials.gov
Study focus
Disease/Condition
Mental Health Issue
Drug/Device/Intervention
Internet Based Intervention - GUIDED
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Anadolu University
Timeline & enrollment
Phase
N/A
Start date
May 01, 2024
End date
Dec 31, 2024
Enrollment
30 participants
Primary outcome

Liebowitz Social Anxiety Scale (LSAS) Turkish Form

Summary

This study is a randomized-controlled trial in which the assumed superiority of the module
 internet-based cognitive behavioral therapy intervention for social anxiety disorder is
 evaluated compared to a waitlist control group. Participants will be assigned to one of two
 groups, treatment which have web-based intervention (guided), and waitlist.
 
 The intervention program will be offered to treatment group participants (guided) through the
 website https://kendikendineyardim.org, the unique online self-help platform in Turkey.
 Participants in the web-based treatment group will receive feedback message within 24 hours
 after each completed module from the guides.

ICD-10 classifications
Mental disorder, not otherwise specifiedMental and behavioural disordersUnspecified mental disorderProblems related to certain psychosocial circumstancesProblems related to other psychosocial circumstances
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06272526
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06272526 through Pure Global AI's free database. This phase not specified trial is sponsored by Anadolu University and is currently Not yet recruiting. The study focuses on Mental Health Issue. Target enrollment is 30 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.